Turquoise Health

Overview

Turquoise Health is a healthcare price-transparency SaaS platform aggregating the largest library of normalized hospital and payer machine-readable file (MRF) data — over 1 billion rates — to power pricing analytics, managed-care contract intelligence, drug reimbursement insights, and direct contracting for providers, payers, employers, life-sciences teams, and health systems. The pharma-relevant wedge is medical-benefit reimbursement intelligence on physician-administered specialty drugs (oncology, immunology, biologics) where reimbursement rates and contract structures vary by geography, provider, and payer.

Turquoise Health is best read as a reimbursement-intelligence and contract-analytics platform, not as an ePA switch, a hub services operator, a BV operations vendor, or an appeals service. For market-access teams, the diligence question is whether MRF-derived rate and contract data improve net-price modeling, contract strategy, and access-team field execution for medical-benefit drugs.

Reimbursement and PA Capability Model

The framework below standardizes how Rx Almanac evaluates reimbursement-prior-auth capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, Turquoise Health is evaluated as intelligence layer, not a transaction or case-processing engine.

Capability	Buyer should compare	Turquoise Health readout
Electronic PA initiation and payer connectivity	ePA submission, payer integrations, plan-specific requirements, real-time decisioning, and transaction reach.	Not the use case. Turquoise is intelligence-only; pair with an ePA vendor for transaction routing.
Benefits verification and coverage discovery	Eligibility, pharmacy/medical benefit checks, policy criteria, coverage route, and reimbursement path identification.	Adjacent. Medical-benefit reimbursement-rate intelligence is the relevant signal for physician-administered specialty drugs; not a real-time BV tool.
Clinical documentation and appeals support	Document collection, criteria matching, appeal packets, peer-to-peer prep, and denial management.	Not the use case. Pair with a hub, appeals vendor, or specialty pharmacy for clinical and appeals workflows.
Provider workflow integration	EHR, portal, fax, call, pharmacy, and practice-management workflows that reduce office burden.	Not the use case. Turquoise is consumed by access strategy, contracting, and analytics teams, not embedded in provider workflows.
Automation, AI, and queue prioritization	AI agents, rules engines, form completion, status retrieval, queue triage, and exception handling.	Core automation workflow. AskTQ AI interface and Clear Contracts AI-driven managed-care contract analysis compress weeks of manual research into seconds.
Reporting, status visibility, and policy intelligence	Case status, payer trend reporting, denial reasons, turnaround metrics, and policy-change intelligence.	Core reporting layer. The platform’s core is normalized MRF reporting, payer-rate analytics, and contract intelligence; Policy Reporter partnership adds policy-change signal.

Buyer Fit

• Right buying motion: Include Turquoise Health when medical-benefit reimbursement intelligence, contract modeling, or net-price diligence is the strategic question for physician-administered specialty drugs.
• Best-fit buyers: Pharma manufacturers (market access, contracting, strategy), providers, payers, employers, and health systems consuming MRF rate and contract data.
• Less ideal fit: Programs whose primary need is PA submission, hub case management, appeals operations, BV workflow, fulfillment, or dispensing — Turquoise does not replace any of these.
• Commercial fit: Subscription pricing; scope data feeds, AskTQ usage, contract-intelligence depth, and reporting expectations in the SOW.
• Data diligence: Confirm payer and product MRF coverage, data freshness, geographic granularity, downstream analytics integration, and whether Policy Reporter integration covers the program’s payer mix.

Differentiators

• Largest normalized MRF library: 1B+ normalized rates across hospital and payer MRF disclosures; the data-asset scale is the structural moat.
• Clear Contracts AI: AI-driven managed-care contract analysis surfaces contract structures and outliers at speed.
• Drug reimbursement insights: Medical-benefit reimbursement-rate data by geography, provider, and payer — directly relevant to physician-administered specialty drug strategy.
• Direct contracting platform: Provider-payer direct contracting workflow sits on top of the rate dataset.
• AskTQ AI interface: Natural-language interface for pricing-intelligence queries; 35% of MAU reported as users at launch.

RFP Questions

• Which MRF coverage, normalization methodology, and refresh cadence apply to the product’s geographic and payer mix?
• How does AskTQ handle pricing queries on physician-administered specialty drugs versus inpatient services?
• What contract-intelligence depth does Clear Contracts deliver for managed-care contracts relevant to the brand?
• How does the Policy Reporter partnership integrate payer policy and formulary signal with rate data?
• What downstream integration options (API, data feed, BI tool connectors) are available for the manufacturer’s analytics environment?
• Which manufacturer market-access references are available, and what use cases (contracting, net price, field execution) are live?

Recent Activity

• 2026-03 - AskTQ launch — AI-powered pricing and contracting layer across Clear Rates, Clear Contracts, and Compliance+ products; reduces manual research from weeks to seconds; 35% of MAU reported as users.
• 2025-04 - Announced a $40M Series C led by Oak HC/FT.
• 2024-10 - NYC Health Care Price Comparison Tool launched on Turquoise data.
• 2024-09 - Policy Reporter by Mercalis strategic data partnership integrating market-coverage data with Turquoise’s price-transparency platform.
• 2024-03 - CPO hire.